Marketgenius
Marketgenius

Vertex Pharmaceuticals Inc

NASDAQ-GS: VRTX
Price: 446,83 USD
+5,09 (1,15%)↑ today
Price at Jun 5, 4:00:01 PM EDT • Market Closed
Loading...

Stock Details

Is it expensive?

Trailing P/E Ratio

Trailing P/E Ratio

Explainer
Trailing P/E shows what you are paying for each dollar of last year's earnings. It answers: "How expensive is this stock relative to its past year's profits?"

26,25

Forward P/E Ratio

Forward P/E Ratio

Explainer
Forward P/E shows what you are paying for each dollar of next year's projected earnings. It answers: "How expensive is this stock relative to its expected future profits?"

20,57

PEG Ratio

PEG Ratio

Explainer
PEG Ratio measures if a stock is expensive relative to its growth rate. It answers: "Am I paying a fair price for growth?"

0,43

Enterprise Value to EBITDA

21,45

Price-to-Sales (TTM)

Price-to-Sales (TTM)

Explainer
Price-to-Sales (TTM) shows what you pay for each dollar of the company's revenue. It answers: "How expensive is this stock relative to sales?"

9,18

Price-to-Book (MRQ)

5,80

Book Value per Share (MRQ)

76,18

Market Cap

Market Cap

Explainer
Market Cap calculates a company's market value. It answers: "How big is this company and what size risk am I taking?"

113,41B

Enterprise Value

106,86B

Is it profitable?

Net Profit Margin (TTM)

Net Profit Margin (TTM)

Explainer
Net Profit Margin (TTM) shows what percentage of revenue remains after all costs. It answers: "How much does the company keep as a final profit?"

35,51%

Gross Profit Margin

Gross Profit Margin

Explainer
Gross Profit Margin shows what percentage of revenue remains after direct costs. It answers: "How much does the company keep before operating costs?"

86,85%

Diluted EPS (TTM)

Diluted EPS (TTM)

Explainer
Diluted EPS (TTM) shows the profit per share over the last 12 months. It answers: "How profitable is each share I buy?"

16,83

Return on Equity (TTM)

24,20%

Revenue (TTM)

12,22B

Is it growing?

Revenue Growth (MRQ)

7,80%

Earnings Growth (YOY)

59,60%

Is it risky?

Beta

0,30

Debt to Equity (MRQ)

10,26

Current Ratio (MRQ)

3,02

Total Debt (MRQ)

1,99B

Who owns it?

Institutional Ownership

97,89%

Insider Ownership

0,20%

Short Interest

1,99%

Shares Outstanding

254,16M

Shares Float

253,02M

Does it pay?

Forward Dividend Yield

0,00%

Payout Ratio

0,00%

Ex. Dividend Date

--

Dividend Date

--

How much cash?

Total Cash (MRQ)

7,25B

Operating Cash Flow (TTM)

4,24B

Levered Free Cash Flow (TTM)

2,78B

Total Cash per Share (MRQ)

28,55

Indicators

Biotechnology

Operating Cash Flow

4,24B

÷

Net Income

4,34B

=

Backed by Cash

0.98

Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.

Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.

Related Heatmaps

NASDAQ 100Index

NASDAQ-100 - NDX

S&P 500Index

S&P 500 - SPX

Loading...

Indicators

Biotechnology

Operating Cash Flow

4,24B

÷

Net Income

4,34B

=

Backed by Cash

0.98

Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.

Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.

Stock Details

Is it expensive?

Trailing P/E Ratio

Trailing P/E Ratio

Explainer
Trailing P/E shows what you are paying for each dollar of last year's earnings. It answers: "How expensive is this stock relative to its past year's profits?"

26,25

Forward P/E Ratio

Forward P/E Ratio

Explainer
Forward P/E shows what you are paying for each dollar of next year's projected earnings. It answers: "How expensive is this stock relative to its expected future profits?"

20,57

PEG Ratio

PEG Ratio

Explainer
PEG Ratio measures if a stock is expensive relative to its growth rate. It answers: "Am I paying a fair price for growth?"

0,43

Enterprise Value to EBITDA

21,45

Price-to-Sales (TTM)

Price-to-Sales (TTM)

Explainer
Price-to-Sales (TTM) shows what you pay for each dollar of the company's revenue. It answers: "How expensive is this stock relative to sales?"

9,18

Price-to-Book (MRQ)

5,80

Book Value per Share (MRQ)

76,18

Market Cap

Market Cap

Explainer
Market Cap calculates a company's market value. It answers: "How big is this company and what size risk am I taking?"

113,41B

Enterprise Value

106,86B

Is it profitable?

Net Profit Margin (TTM)

Net Profit Margin (TTM)

Explainer
Net Profit Margin (TTM) shows what percentage of revenue remains after all costs. It answers: "How much does the company keep as a final profit?"

35,51%

Gross Profit Margin

Gross Profit Margin

Explainer
Gross Profit Margin shows what percentage of revenue remains after direct costs. It answers: "How much does the company keep before operating costs?"

86,85%

Diluted EPS (TTM)

Diluted EPS (TTM)

Explainer
Diluted EPS (TTM) shows the profit per share over the last 12 months. It answers: "How profitable is each share I buy?"

16,83

Return on Equity (TTM)

24,20%

Revenue (TTM)

12,22B

Is it growing?

Revenue Growth (MRQ)

7,80%

Earnings Growth (YOY)

59,60%

Is it risky?

Beta

0,30

Debt to Equity (MRQ)

10,26

Current Ratio (MRQ)

3,02

Total Debt (MRQ)

1,99B

Who owns it?

Institutional Ownership

97,89%

Insider Ownership

0,20%

Short Interest

1,99%

Shares Outstanding

254,16M

Shares Float

253,02M

Does it pay?

Forward Dividend Yield

0,00%

Payout Ratio

0,00%

Ex. Dividend Date

--

Dividend Date

--

How much cash?

Total Cash (MRQ)

7,25B

Operating Cash Flow (TTM)

4,24B

Levered Free Cash Flow (TTM)

2,78B

Total Cash per Share (MRQ)

28,55

Related Heatmaps

NASDAQ 100Index

NASDAQ-100 - NDX

S&P 500Index

S&P 500 - SPX